{"Abstract": [0], "Breakthroughs": [1], "in": [2, 104, 147, 166], "molecular": [3, 22], "medicine": [4], "have": [5], "positioned": [6], "the": [7, 12, 20, 25, 28, 44, 49, 53, 64, 75, 110, 139, 142, 156, 169], "amyloid-\u03b2": [8], "(A\u03b2)": [9], "pathway": [10, 26, 102], "at": [11], "center": [13], "of": [14, 24, 48, 57, 66, 79, 100, 116, 141, 145, 150, 172], "Alzheimer\u2019s": [15], "disease": [16], "(AD)": [17], "pathophysiology.": [18], "While": [19], "detailed": [21], "mechanisms": [23], "and": [27, 36, 59, 73, 91, 129, 159], "spatial-temporal": [29], "dynamics": [30], "leading": [31], "to": [32, 88], "synaptic": [33], "failure,": [34], "neurodegeneration,": [35], "clinical": [37], "onset": [38], "are": [39, 60], "still": [40], "under": [41], "intense": [42], "investigation,": [43], "established": [45], "biochemical": [46], "alterations": [47], "A\u03b2": [50, 80, 101, 118], "cycle": [51], "remain": [52], "core": [54], "biological": [55, 123], "hallmark": [56], "AD": [58, 105], "promising": [61], "targets": [62], "for": [63, 162, 168], "development": [65, 144, 167], "disease-modifying": [67], "therapies.": [68], "Here,": [69], "we": [70], "systematically": [71], "review": [72, 154], "update": [74], "vast": [76], "state-of-the-art": [77], "literature": [78], "science": [81], "with": [82, 120], "evidence": [83, 111], "from": [84], "basic": [85], "research": [86], "studies": [87], "human": [89], "genetic": [90], "multi-modal": [92], "biomarker": [93], "investigations,": [94], "which": [95], "supports": [96], "a": [97, 113, 135], "crucial": [98], "role": [99], "dyshomeostasis": [103], "pathophysiological": [106], "dynamics.": [107], "We": [108], "discuss": [109], "highlighting": [112], "differentiated": [114], "interaction": [115], "distinct": [117], "species": [119], "other": [121], "AD-related": [122], "mechanisms,": [124], "such": [125], "as": [126, 132, 134], "tau-mediated,": [127], "neuroimmune": [128], "inflammatory": [130], "changes,": [131], "well": [133], "neurochemical": [136], "imbalance.": [137], "Through": [138], "lens": [140], "latest": [143], "multimodal": [146], "vivo": [148], "biomarkers": [149], "AD,": [151], "this": [152], "cross-disciplinary": [153], "examines": [155], "compelling": [157], "hypothesis-": [158], "data-driven": [160], "rationale": [161], "A\u03b2-targeting": [163], "therapeutic": [164], "strategies": [165], "early": [170], "treatment": [171], "AD.": [173]}